We are live on ! Find out more
GC

Gratus Capital Portfolio holdings

AUM $2.5B
1-Year Est. Return 32.89%
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
+32.89%
3 Year Est. Return
+51.43%
5 Year Est. Return
+136.95%
10 Year Est. Return
–
AUM
$1.22B
AUM Growth
+$273M
Cap. Flow
+$212M
Cap. Flow %
17.41%
Top 10 Hldgs %
29.14%
Holding
236
New
31
Increased
72
Reduced
73
Closed
11

Top Buys

Rank Stock Value
1
IEFA icon
iShares Core MSCI EAFE ETF
IEFA
+$54.1M
2
VUG icon
Vanguard Morningstar Growth ETF
VUG
+$38.4M
3
UYLD icon
Angel Oak UltraShort Income ETF
UYLD
+$25.1M
4
CTA icon
Simplify Managed Futures Strategy ETF
CTA
+$16M
5
WMT icon
Walmart Inc
WMT
+$14.1M

Top Sells

Rank Stock Value
1
MS icon
Morgan Stanley
MS
+$14.5M
2
BX icon
Blackstone
BX
+$12M
3
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
+$9.81M
4
EW icon
Edwards Lifesciences
EW
+$8.64M
5
PUBM icon
PubMatic
PUBM
+$8.1M

Sector Composition

Rank Sector Weight
1 Technology 16.59%
2 Healthcare 10.78%
3 Industrials 9.91%
4 Energy 8.62%
5 Consumer Staples 6.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AON icon
76
Aon
AON
$76.5B
$2.9M 0.24%
9,652
-100
-1% -$29.2K
LOW icon
77
Lowe's Companies
LOW
$117B
$2.77M 0.23%
13,892
+21
+0.2% +$4.2K
KO icon
78
Coca-Cola
KO
$377B
$2.76M 0.23%
43,318
-1,388
-3% -$83.8K
AMZN icon
79
Amazon
AMZN
$2.92T
$2.74M 0.23%
32,629
-12,771
-28% -$1.26M
JPST icon
80
JPMorgan Ultra-Short Income ETF
JPST
$40.1B
$2.63M 0.22%
52,438
-46,355
-47% -$2.32M
PTGX icon
81
Protagonist Therapeutics
PTGX
$8.79B
$2.39M 0.2%
219,059
+12,946
+6% +$109K
NTLA icon
82
Intellia Therapeutics
NTLA
$1.49B
$2.35M 0.19%
+67,311
New +$3.2M
IMUX icon
83
Immunic
IMUX
$190M
$2.34M 0.19%
166,829
+91,510
+121% +$2.5M
CVX icon
84
Chevron
CVX
$392B
$2.32M 0.19%
12,898
+247
+2% +$43.1K
NVO
85
Novo Nordisk
NVO
$208B
$2.31M 0.19%
34,194
– –
TEL icon
86
TE Connectivity
TEL
$59.6B
$2.29M 0.19%
19,980
-376
-2% -$44.7K
MCD icon
87
McDonald's
MCD
$192B
$2.23M 0.18%
8,470
-43
-0.5% -$11.3K
COKE icon
88
Coca-Cola Consolidated
COKE
$12.5B
$2.22M 0.18%
43,260
– –
BDX icon
89
Becton Dickinson
BDX
$45.6B
$2.19M 0.18%
8,619
-98
-1% -$23.1K
HPQ icon
90
HP
HPQ
$24.9B
$2.11M 0.17%
78,391
– –
HPQ icon
91
PUT
HP
HPQ
$24.9B
– –
0
– –
TSLA icon
92
Tesla
TSLA
$1.23T
$1.98M 0.16%
+16,096
New +$3.05M
AX icon
93
Axos Financial
AX
$5.77B
$1.91M 0.16%
49,943
-196
-0.4% -$7.47K
BRK.A icon
94
Berkshire Hathaway Class A
BRK.A
$1.1T
$1.87M 0.15%
+4
New +$1.8M
GOOG icon
95
Alphabet (Google) Class C
GOOG
$4.36T
$1.83M 0.15%
20,603
+10
+0% +$954
LLY icon
96
Eli Lilly
LLY
$1.02T
$1.82M 0.15%
4,963
+70
+1% +$24.8K
PG icon
97
Procter & Gamble
PG
$336B
$1.79M 0.15%
11,793
-311
-3% -$43.6K
SYK icon
98
Stryker
SYK
$125B
$1.69M 0.14%
6,932
-60
-0.9% -$13.6K
META icon
99
Meta Platforms (Facebook)
META
$1.42T
$1.66M 0.14%
13,787
-25
-0.2% -$2.94K
NEE icon
100
NextEra Energy
NEE
$181B
$1.61M 0.13%
19,217
+140
+0.7% +$11.3K
2 3
4
5 6

Similar funds

LFDLE
La Financiere de L'Echiquier Paris, France $2.29B AUM 37.29% 1-Year Est. Return
CDH
Charles D. Hyman $1.79B AUM 17.18% 1-Year Est. Return
AT
Arvest Trust Bartlesville, Oklahoma $1.68B AUM 14.24% 1-Year Est. Return
BPCA
Bank Pictet & Cie (Asia) Singapore $1.57B AUM 25.56% 1-Year Est. Return
HIG
Herr Investment Group Austin, Texas $1.5B AUM 29.27% 1-Year Est. Return
H
HoyleCohen San Diego, California $1.32B AUM 27.05% 1-Year Est. Return
PRIG
Payden & Rygel Investment Group Los Angeles, California $1.24B AUM
PO
Private Ocean San Rafael, California $1.13B AUM 11.01% 1-Year Est. Return

Gratus Capital's Q4 2022 Portfolio in Review

As of Q4 2022, Gratus Capital held 236 positions worth $1.22B, up 29% from $945M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Gratus Capital deployed $212M of net new capital in Q4 2022, opening 31 new positions and adding to 72 existing holdings. Its largest new stake was iShares Core MSCI EAFE ETF: 918,749 shares worth $56.6M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 19% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Morgan Stanley, an estimated $14.5M trimmed.

  • Gratus Capital's largest Q4 2022 buy was iShares Core MSCI EAFE ETF: 918,749 shares worth $56.6M.
  • Gratus Capital added most to Vanguard Morningstar Growth ETF in Q4 2022, an estimated $38.4M increase.
  • Gratus Capital's biggest Q4 2022 reduction was Morgan Stanley, cutting an estimated $14.5M.
  • Gratus Capital fully exited PubMatic in Q4 2022, selling an estimated $8.1M.
  • Gratus Capital's ten largest holdings make up 29% of its $1.22B portfolio in Q4 2022.
  • Gratus Capital opened 31 new positions and closed 11 in Q4 2022.
  • Gratus Capital's portfolio value rose 29% quarter-over-quarter to $1.22B.

Based on Gratus Capital's 13F filing for Q4 2022, filed 27 Jan 2023.